These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 20007976

  • 1. Liver X receptor agonists augment human islet function through activation of anaplerotic pathways and glycerolipid/free fatty acid cycling.
    Ogihara T, Chuang JC, Vestermark GL, Garmey JC, Ketchum RJ, Huang X, Brayman KL, Thorner MO, Repa JJ, Mirmira RG, Evans-Molina C.
    J Biol Chem; 2010 Feb 19; 285(8):5392-404. PubMed ID: 20007976
    [Abstract] [Full Text] [Related]

  • 2. The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.
    Scholz H, Lund T, Dahle MK, Collins JL, Korsgren O, Wang JE, Foss A.
    Diabetologia; 2009 Jul 19; 52(7):1352-62. PubMed ID: 19415233
    [Abstract] [Full Text] [Related]

  • 3. Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines.
    Meng ZX, Yin Y, Lv JH, Sha M, Lin Y, Gao L, Zhu YX, Sun YJ, Han X.
    Diabetologia; 2012 Jun 19; 55(6):1733-44. PubMed ID: 22415588
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effect of LXR activation on cell proliferation and cell cycle progression through lipogenic activity.
    Kim KH, Lee GY, Kim JI, Ham M, Won Lee J, Kim JB.
    J Lipid Res; 2010 Dec 19; 51(12):3425-33. PubMed ID: 20847297
    [Abstract] [Full Text] [Related]

  • 5. Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels.
    Zitzer H, Wente W, Brenner MB, Sewing S, Buschard K, Gromada J, Efanov AM.
    Endocrinology; 2006 Aug 19; 147(8):3898-905. PubMed ID: 16644917
    [Abstract] [Full Text] [Related]

  • 6. Activation of liver X receptor decreases atherosclerosis in Ldlr⁻/⁻ mice in the absence of ATP-binding cassette transporters A1 and G1 in myeloid cells.
    Kappus MS, Murphy AJ, Abramowicz S, Ntonga V, Welch CL, Tall AR, Westerterp M.
    Arterioscler Thromb Vasc Biol; 2014 Feb 19; 34(2):279-84. PubMed ID: 24311381
    [Abstract] [Full Text] [Related]

  • 7. Fetal liver X receptor activation acutely induces lipogenesis but does not affect plasma lipid response to a high-fat diet in adult mice.
    van Straten EM, van Meer H, Huijkman NC, van Dijk TH, Baller JF, Verkade HJ, Kuipers F, Plösch T.
    Am J Physiol Endocrinol Metab; 2009 Nov 19; 297(5):E1171-8. PubMed ID: 19724022
    [Abstract] [Full Text] [Related]

  • 8. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
    Briand O, Touche V, Colin S, Brufau G, Davalos A, Schonewille M, Bovenga F, Carrière V, de Boer JF, Dugardin C, Riveau B, Clavey V, Tailleux A, Moschetta A, Lasunción MA, Groen AK, Staels B, Lestavel S.
    Gastroenterology; 2016 Mar 19; 150(3):650-8. PubMed ID: 26602218
    [Abstract] [Full Text] [Related]

  • 9. Liver X receptor activation inhibits SGLT2-mediated glucose transport in human renal proximal tubular cells.
    Chonlaket P, Wongwan T, Soodvilai S.
    Exp Physiol; 2018 Feb 01; 103(2):250-260. PubMed ID: 29127736
    [Abstract] [Full Text] [Related]

  • 10. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα.
    Ducheix S, Podechard N, Lasserre F, Polizzi A, Pommier A, Murzilli S, Di Lisio C, D'Amore S, Bertrand-Michel J, Montagner A, Pineau T, Loiseau N, Lobaccaro JM, Martin PG, Guillou H.
    Biochimie; 2013 Mar 01; 95(3):556-67. PubMed ID: 23063693
    [Abstract] [Full Text] [Related]

  • 11. Negative regulation of Hedgehog signaling by liver X receptors.
    Kim WK, Meliton V, Park KW, Hong C, Tontonoz P, Niewiadomski P, Waschek JA, Tetradis S, Parhami F.
    Mol Endocrinol; 2009 Oct 01; 23(10):1532-43. PubMed ID: 19608643
    [Abstract] [Full Text] [Related]

  • 12. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
    Green CD, Jump DB, Olson LK.
    Endocrinology; 2009 Jun 01; 150(6):2637-45. PubMed ID: 19228891
    [Abstract] [Full Text] [Related]

  • 13. Liver X receptor activation inhibits osteoclastogenesis by suppressing NF-κB activity and c-Fos induction and prevents inflammatory bone loss in mice.
    Kim HJ, Yoon KA, Yoon HJ, Hong JM, Lee MJ, Lee IK, Kim SY.
    J Leukoc Biol; 2013 Jul 01; 94(1):99-107. PubMed ID: 23657115
    [Abstract] [Full Text] [Related]

  • 14. A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor.
    Blaschke F, Takata Y, Caglayan E, Collins A, Tontonoz P, Hsueh WA, Tangirala RK.
    Circ Res; 2006 Dec 08; 99(12):e88-99. PubMed ID: 17110595
    [Abstract] [Full Text] [Related]

  • 15. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms.
    Morello F, Saglio E, Noghero A, Schiavone D, Williams TA, Verhovez A, Bussolino F, Veglio F, Mulatero P.
    Atherosclerosis; 2009 Nov 08; 207(1):38-44. PubMed ID: 19426978
    [Abstract] [Full Text] [Related]

  • 16. Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule.
    Kittayaruksakul S, Soodvilai S, Asavapanumas N, Muanprasat C, Chatsudthipong V.
    Am J Physiol Renal Physiol; 2012 Mar 01; 302(5):F552-60. PubMed ID: 22169006
    [Abstract] [Full Text] [Related]

  • 17. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M, Filomenko R, Rébé C, Chevriaux A, Varin A, Derangère V, Bessède G, Gambert P, Lagrost L, Masson D.
    Biochem Pharmacol; 2013 Jul 01; 86(1):122-9. PubMed ID: 23313547
    [Abstract] [Full Text] [Related]

  • 18. Liver X receptor agonists decrease ENaC-mediated sodium transport in collecting duct cells.
    Soodvilai S, Jia Z, Fongsupa S, Chatsudthipong V, Yang T.
    Am J Physiol Renal Physiol; 2012 Dec 15; 303(12):F1610-6. PubMed ID: 23077096
    [Abstract] [Full Text] [Related]

  • 19. Lxr regulates lipid metabolic and visual perception pathways during zebrafish development.
    Pinto CL, Kalasekar SM, McCollum CW, Riu A, Jonsson P, Lopez J, Swindell EC, Bouhlatouf A, Balaguer P, Bondesson M, Gustafsson JÅ.
    Mol Cell Endocrinol; 2016 Jan 05; 419():29-43. PubMed ID: 26427652
    [Abstract] [Full Text] [Related]

  • 20. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
    Jung YA, Kim HK, Bae KH, Seo HY, Kim HS, Jang BK, Jung GS, Lee IK, Kim MK, Park KG.
    Exp Mol Med; 2014 Jan 24; 46(1):e73. PubMed ID: 24458133
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.